Navigation Links
Poultry workers at increased risk of carrying antibiotic-resistant E. coli
Date:12/17/2007

Poultry workers in the United States are 32 times more likely to carry E. coli bacteria resistant to the commonly used antibiotic, gentamicin, than others outside the poultry industry, according to a recent study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health. While drug-resistant bacteria, such as E. coli, are common in the industrial broiler chicken environment, this is the first U.S. research to show exposure occurring at a high level among industrial poultry workers. The results are published in the December, 2007, edition of Environmental Health Perspectives.

The use of antimicrobials in industrial food production has been going on for over 50 years in the United States, said the studys lead author, Lance B. Price, who serves on the research faculty at the Johns Hopkins School of Medicine, Division of Infectious Disease, and is a scientific advisor to the Johns Hopkins Center for a Livable Future. Some estimates indicate that well over half of the antimicrobial drugs produced in the United States are used in food animal production. In the U.S. alone, over nine billion food animals are produced annually.

The study was conducted with poultry workers and community residents in the eastern shore regions of Maryland and Virginia, and it confirms similar studies in Europe showing that poultry farmers and workers are at risk of exposure to drug resistant E. coli bacteria. The Maryland and Virginia regions on the Delmarva Peninsula are among the top broiler chicken producing regions in the U.S., producing more than 600 million chickens annually.

In the study, researchers conducted in-depth analyses of 49 study participants, 16 working within the poultry industry and 33 community residents. Stool samples from the participants were tested for resistance to the antimicrobials ampicillin, ciprofloxacin, ceftriazone, gentamicin and tetracycline. Findings showed that poultry workers had 32 times greater odds of being colonized with gentamicin-resistant E. coli than other members of the community.

One of the major implications of this study is to underscore the importance of the non-hospital environment in the origin of drug resistant infections, said Ellen K. Silbergeld, PhD, senior author of the study.

Price, PhD, and other researchers note that as food animal production shifted from the independent farmer to large-scale, industrialized operations, the use of antimicrobials in feeds intended to stimulate growth has increased. Currently 16 different antimicrobial drugs are approved for use in U.S. poultry production with gentamicin reported to be the most widely used.


'/>"/>

Contact: Tim Parsons
paffairs@jhsph.edu
410-955-6878
Johns Hopkins University Bloomberg School of Public Health
Source:Eurekalert

Related biology news :

1. Thermochemical process converts poultry litter into bio-oil
2. Survey finds elevated rates of new asthma among WTC rescue and recovery workers
3. Scientists develop a fast system to detect metal concentrations in iron and steel industry workers
4. Western diet linked to increased risk of colon cancer recurrence
5. International team shows mercury concentrations in fish respond quickly to increased deposition
6. International team shows mercury concentrations in fish respond quickly to increased deposition
7. Weight gain between first and second pregnancies associated with increased odds of male second child
8. Social stress + darkness = increased anxiety
9. Baker Institute finds increased domestic production wont make US self-sufficient in natural gas
10. Research forecasts increased chances for stormy weather
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... and PUNE, India , January 19, 2017 ... Biometric Sensor Market, Opportunities and Forecast, 2014 - 2022," the global biometric ... CAGR of 9.6% from 2016 to 2022. In 2015, Asia-Pacific ... security for both public and private sectors. Continue ... ...
(Date:1/13/2017)... 13, 2017 Sandata Technologies, LLC, a ... homecare industry, including Electronic Visit Verification™ (EVV™), announced ... Jugs, as Senior Vice President of Product Management. ... of homecare experience to Sandata, where he will ... to align Sandata,s suite of solutions with the ...
(Date:1/11/2017)... 11, 2017 Intoxalock, a leading ignition interlock ... of its patent-pending calibration device. With this new technology, ... securely upload data logs and process repairs at service ... "Fighting drunk driving through the application of cutting-edge ... large, but also for the customer who can get ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)("Interpace" ... useful molecular diagnostic tests and pathology services, today ... purchase agreement with three  institutional investors to purchase ... in a registered direct offering.  In a concurrent ... to the same investors warrants to purchase 855,000 ...
(Date:1/21/2017)... 2017   Boston Biomedical , an industry leader ... cancer stemness pathways, today presented data from two clinical ... 2017 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers ... In a Phase Ib/II study of napabucasin ... cancer stemness pathways by targeting STAT3 – colorectal cancer ...
(Date:1/20/2017)... Ginkgo Bioworks, the organism company, announced ... the synthesis and assembly of DNA. The acquisition ... synthetic DNA into Ginkgo,s automated organism engineering foundries, ... of new organism designs for application across a ... founded to significantly increase the world,s capacity to ...
(Date:1/19/2017)... 19, 2017 Research and Markets has announced ... Biomolecules, Cancer Type, Application - Global Opportunity Analysis and Industry Forecast, ... ... global market is projected to reach $15,737 million by 2022 from ... to 2022. Omic technologies segment accounted for more ...
Breaking Biology Technology: